ARIDIS PHARMACEUTICALS INC (ARDS) Earnings History & Surprises

NASDAQ:ARDS • US0403341045

Current stock price

0.3101 USD
+0.05 (+17.91%)
At close:
0.2619 USD
-0.05 (-15.54%)
After Hours:

ARDS Earnings overview

Past quarterly earnings results for ARIDIS PHARMACEUTICALS INC (ARDS), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Aug 14, 2023

Last Reported

Most Recent
Release Date
Jun 8, 2023
Period
Q1 / 2023
EPS Reported
EPS Surprise
%
Revenue Surprise
%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q1 2023 - - 1.082M - -8.85%
Q4 2022 -0.60 -0.42 -43.47% 34.78% 1.213M 314.497K 285.70% 22.90%
Q3 2022 -0.47 -0.17 -171.05% 75.77% 399K 7.616M -94.76% -22.52%
Q2 2022 -0.45 -0.06 -635.29% 18.18% 292K 10.672M -97.26% 784.85%
Q1 2022 -0.44 -0.52 15.42% 42.86% 1.187M 2.04M -41.81% -
Q4 2021 -0.92 -0.42 -119.99% -55.93% 987K 1.938M -49.07% -
Q3 2021 -1.94 -0.52 -270.51% -198.46% 515K 170.003K 202.94% -
Q2 2021 -0.55 -0.64 14.07% -17.02% 33K 306K -89.22% -96.70%
Q1 2021 -0.77 -0.63 -22.25% -5.48% 102K -100.00% -
Q4 2020 -0.59 -0.61 2.51% - 510K -100.00% -
Q3 2020 -0.65 -0.64 -1.47% - 318.75K -100.00% -
Q2 2020 -0.47 -0.76 38.07% - 1M 275.4K 263.11% -
Q1 2020 -0.73 -0.68 -6.82% - 318.75K -100.00% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

ARDS EPS Q2Q GrowthARDS EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 0 50 -50 -100 -150

Revenue Historical Q2Q growth and Acceleration

ARDS Revenue Q2Q GrowthARDS Revenue Q2Q GrowthRevenue Q2Q Growth Q2/21 Q2/22 Q3/22 Q4/22 Q1/23 0 200 400 600

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
0
Average EPS beat (4)
-283.27%
Max EPS beat (4)
-43.47%
Min EPS beat (4)
-635.29%

Revenue beat statistics

Revenue beat (4)
1
Average Revenue beat (4)
31.22%
Max Revenue beat (4)
285.70%
Min Revenue beat (4)
-97.26%

Analysis

In the last 4 quarters, ARDS has not beaten EPS estimates in any release
ARDS has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, ARDS reported -283.3% below the EPS estimates on average.
In the last 4 quarters, ARDS has beaten the revenue estimates by 31.2% on average.
ARDS Overview ARDS Technical Analysis Report ARDS Fundamental Analysis Report ARDS Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

ARIDIS PHARMACEUTICALS INC / ARDS Earnings FAQ

When did ARIDIS PHARMACEUTICALS INC (ARDS) report earnings last quarter?

ARIDIS PHARMACEUTICALS INC (ARDS) last reported earnings on 6/8/2023.

Did ARDS stock beat earnings estimates in the most recent quarter?

ARIDIS PHARMACEUTICALS INC (ARDS) missed EPS estimates and missed revenue estimates in the most recent quarter.

Can you provide information on how often ARIDIS PHARMACEUTICALS INC beats earnings estimates?

In the last 4 quarters, ARIDIS PHARMACEUTICALS INC (ARDS) has beaten EPS estimates in 0 out of 4 releases.